Clinical Trial

Endovascular Treatment for eXtra-Large Ischemic Stroke

Study acronym: XL STROKE-2
Recruiting
View on ClinicalTrials.gov →
Summary
The role of endovascular thrombectomy in patients with extra-large ischemic burden is still unclear. The XL STROKE-2 randomized trial is aiming to investigate the efficacy and safety of mechanical thrombectomy in acute extra-large ischemic stroke patients with large vessel occlusion.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-04-24; most recent amendment 2025-12-18.
Status change: Not Yet Recruiting → Recruiting 2024-10-23
Trial Details
NCT Number NCT06388148
Lead Sponsor Zhongming Qiu
Collaborators: The First Affiliated Hospital of University of South China, Xiangtan Central Hospital, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Longyan City First Hospital, Taizhou First People's Hospital, Zhangzhou Affiliated Hospital of Fujian Medical University
Conditions Stroke, Acute Ischemic
Enrollment 286 participants
Start Date 2024-06-16
Primary Completion 2026-10-31 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-26